poisar

News

Current market catalysts

Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.

Latest Coverage

Latest Headlines

30 headlines

  21. Na

    Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy

    Iovance Biotherapeutics will host a webcast on October 29, 2026 to present positive results from the IOV-LUN-202 Phase 2 trial of lifileucel TIL therapy for previously treated nonsquamous metastatic non-small cell lung cancer, along with updates on precision medicine opportunities for its TIL platform.

    IOVA
  22. Rosen Law Firm

    ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gildan Activewear Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GIL

    Rosen Law Firm is reminding investors who purchased Gildan Activewear securities between February 19, 2025 and June 15, 2026 of the December 14, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Gildan made false statements regarding its business operations, lacked adequate internal controls, and engaged in channel stuffing to artificially inflate revenue figures.

    GIL
  23. Adam Spatacco

    History Shows IPO Stocks Plunge Up to 48% Within 1 Year of Going Public. Here's Why SpaceX Could Defy the Odds in 2027.

    While IPO stocks historically experience median drawdowns of up to 48% in their first year, SpaceX could defy this trend due to its diversified business model. The company's growth engines include Starlink (13.6M subscribers, 89% YoY growth), AI infrastructure contracts worth billions (including $120.5B with Anthropic and $11B annualized with Alphabet), and a potential merger with Tesla. However, investors should remain disciplined about valuation and the company's ability to convert revenue into free cash flow.

    SPCXTSLAGOOGGOOGLGOOGM
  24. Keithen Drury

    Not Space. Not Starlink. Here's My Top Reason to Buy SpaceX Stock.

    SpaceX's Super Intelligence (SI) division, which houses its AI data center platform and Grok language models, is emerging as the company's primary growth driver rather than its space launch or Starlink services. SI achieved $7.56 billion in Q3 2026 revenue (830% year-over-year growth) and posted $431 million in operating profit, with the company investing $16.4 billion in capital expenditures for this segment, signaling strong confidence in its AI future.

    SPCX
  25. Keith Noonan

    2 Millionaire-Maker Custom Silicon Stocks Powering the AI Infrastructure Supercycle

    Broadcom and Taiwan Semiconductor Manufacturing (TSMC) are highlighted as two leading players in custom silicon for AI infrastructure. Broadcom designs ASICs for major tech companies like Alphabet, Meta, and OpenAI, with Q3 AI semiconductor revenue up 221% year-over-year. TSMC manufactures high-end chips and controls over 90% of the advanced AI chip market. Both stocks have delivered exceptional long-term returns, though they face recent valuation volatility amid AI industry concerns.

    AVGOTSM
  26. Sarah Sidlow

    Vanguard Small-Cap ETF vs JPMorgan BetaBuilders Compared

    Vanguard Morningstar Small-Cap ETF (VB) and JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) offer different approaches to small-cap investing. Vanguard offers lower costs (0.03% vs 0.09% expense ratio), significantly higher assets ($175.8B vs $740M), and broader exposure with 1,357 holdings. JPMorgan provides a more concentrated portfolio of 847 holdings with slightly higher 1-year returns (13.8% vs 13.2%). Both are solid options depending on investor preferences for breadth versus concentration.

    VBBBSC
  27. Bragar Eagel & Squire, P.C.

    Anavex Life Sciences Corp. Investors Seeking Lead Plaintiff Role Have Until November 30th to Contact Bragar Eagel & Squire, P.C.

    A class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) for allegedly making false and misleading statements regarding inadequate internal controls and understated regulatory challenges related to misconduct by former CEO Christopher Missling. Investors who purchased securities between November 26, 2025 and August 28, 2026 can apply to be lead plaintiff by November 30, 2026.

    AVXL
  28. Bragar Eagel & Squire, P.C.

    DAVA STOCKHOLDER ALERT: Endava plc Investors Have Until November 30th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role

    A class action lawsuit has been filed against Endava plc (NASDAQ: DAVA) for allegedly making false and misleading statements regarding accounting treatment of customer and supplier agreements, delayed financial results, and ineffective internal controls. Investors who purchased Endava securities between September 4, 2025 and September 21, 2026 have until November 30, 2026 to apply as lead plaintiff.

    DAVA
  29. Keithen Drury

    Prediction: This Will Be SpaceX's Stock Price in 3 Years

    SpaceX analyst predicts the stock could reach $375 per share within three years, more than doubling from current levels. The growth driver isn't the traditional rocket launch business, but rather the high-growth Starlink connectivity division (69% YoY growth) and the super intelligence/AI segment (830% YoY growth). If SpaceX achieves CEO Elon Musk's ambitious $500 billion to $1 trillion annualized recurring revenue target by end of 2027 and trades at 10x sales, it could become a $5 trillion company.

    SPCX
  30. Bragar Eagel & Squire, P.C.

    QFIN STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Qfin Holdings, Inc. and Encourages Investors to Contact the Firm

    A class action lawsuit has been filed against Qfin Holdings, Inc. for allegedly making false and misleading statements about the resiliency of its business and downplaying the negative impact of regulatory headwinds during the period between March 18, 2026 and August 25, 2026. Investors who suffered losses are encouraged to contact the law firm, with a deadline of November 30, 2026 to apply as lead plaintiff.

    QFIN
Source
Source-attributed market-news archive
Observed
Checked
Cadence
Continuous captured-news feed
Status
fresh